SSII
SS Innovations International, Inc.NASDAQHealthcare$5.00+3.09%ClosedMarket Cap: $971.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
24.86
P/S
22.88
EV/EBITDA
-154.11
DCF Value
$-16.69
FCF Yield
-2.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
45.3%
Operating Margin
-19.7%
Net Margin
-28.6%
ROE
-30.2%
ROA
-16.3%
ROIC
-17.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $14.5M | 41.7% | $-698.0K | $-2.5M | $-0.01 | — |
| FY 2025 | $42.4M | 43.4% | $-8.2M | $-12.1M | $-0.06 | — |
| Q3 2025 | $12.8M | 48.1% | $-1.8M | $-3.7M | $-0.02 | — |
| Q2 2025 | $10.0M | 59.1% | $97.0K | $-256.7K | $-0.00 | — |
| Q1 2025 | $5.1M | 21.2% | $-5.9M | $-5.7M | $-0.03 | — |
| Q4 2024 | $5.6M | 53.9% | $-7.6M | $-7.5M | $-0.04 | — |
| FY 2024 | $20.6M | 40.9% | $-19.0M | $-19.2M | $-0.10 | — |
| Q3 2024 | $4.4M | 52.8% | $-3.2M | $-3.2M | $-0.02 | — |
| Q2 2024 | $4.4M | 16.8% | $-2.8M | $-2.9M | $-0.02 | — |
| Q1 2024 | $6.9M | 42.3% | $-2.7M | $-2.8M | $-0.02 | — |
| Q4 2023 | $1.4M | -13.3% | $-15.5M | $-16.1M | $-0.09 | — |
| FY 2023 | $5.9M | 12.1% | $-20.7M | $-20.9M | $-0.16 | — |